To investigate whether expression of the three factors was regulated in an Wnt/β-catenin-dependent manner in liver cancer, we treated HuH-7 cells with a GSK-3α/β inhibitor, CHIR-99021, and examined their expression. Here, GSK3A is linked to liver cancer.